Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Osteoporos Int

Search In Journal Title:

Abbravation: Osteoporosis International

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1007/s35144-015-0793-5

Search In DOI:

ISSN

1433-2965

Search In ISSN:
Search In Title Of Papers:

Place of residence and risk of fracture in older p

Authors: Julieann Brennan nee Saunders Antony Johansen John Butler Mike Stone Peter Richmond Sarah Jones Ronan A Lyons
Publish Date: 2003/04/30
Volume: 14, Issue: 6, Pages: 515-519
PDF Link

Abstract

Fracture prevention strategies will be most costeffective if targeted on groups of frail elderly people who are at particularly high risk of falls and fractures Elderly people living in care homes are one potential target population but fracture incidence in this setting remains poorly defined in many countries We used the All Wales Injury Surveillance System AWISS in a populationbased study of people aged over 65 years living in the city of Cardiff We linked a postcodebased register of all sheltered accommodation and all residential and nursing homes in the city with injury data from Cardiffs single Accident and Emergency Department Cardiff has 47700 residents aged over 65 years with 1918 40 living in residential or nursing homes and 1868 39 in sheltered accommodation In 1999 we identified a total of 1305 fractures including 366 hip fractures giving a crude fracture incidence of 274/1000 per year and 77/1000 per year respectively Care home residents suffered 213 fractures 95 of which were of the hip giving a crude fracture incidence of 1111/1000 per year and 495/1000 per year respectively People living in sheltered accommodation suffered 94 fractures including 28 at the hip giving a crude fracture incidence of 514/1000 per year and 153/1000 per year respectively People in care homes and sheltered accommodation tend to be older than those living in the community and we adjusted for this by calculating age and genderstandardized relative ratios for each setting Compared with the community dwelling population care home residents had an overall fracture risk of 29 95 CI 25–33 and a hip fracture risk of 33 95 CI 26–42 People in sheltered accommodation had a total fracture risk of 17 95 CI 14–21 and a hip fracture risk of 16 95 CI 11–24 Such figures support the potential costeffectiveness of strategies that seek to prevent fractures in care homes and sheltered accommodation and are of special interest to those planning intervention studies in these settings

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Development of an electronic medical record based intervention to improve medical care of osteoporosis
  2. Morbidity following lower extremity fractures in men with spinal cord injury
  3. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass
  4. Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women
  5. Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
  6. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis
  7. Oral bisphosphonates and risk of ischemic stroke: a case–control study
  8. The association between serum osteocalcin levels and metabolic syndrome in Koreans
  9. Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients
  10. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
  11. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review
  12. Genetic analysis of serum osteocalcin and bone mineral in multigenerational Afro-Caribbean families
  13. Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients
  14. Declining incidence of low-trauma knee fractures in elderly women: nationwide statistics in Finland between 1970 and 2006
  15. Changing health behaviors with social marketing
  16. Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga
  17. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis
  18. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older
  19. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
  20. One year outcomes and costs following a vertebral fracture
  21. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
  22. Classification of women with and without hip fracture based on quantitative computed tomography and finite element analysis
  23. Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men
  24. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women
  25. Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study
  26. Tracking of size-adjusted bone mineral content and bone area in boys and girls from 10 to 17 years of age
  27. Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over
  28. Age-related hyperkyphosis, independent of spinal osteoporosis, is associated with impaired mobility in older community-dwelling women
  29. Performance of COLIA1 Polymorphism and Bone Turnover Markers to Identify Postmenopausal Women with Prevalent Vertebral Fractures
  30. Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US
  31. Vitamin D status in men with psoriatic arthritis: a case-control study
  32. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate
  33. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™
  34. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture
  35. De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient
  36. Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats
  37. Precision of 18 F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
  38. RETRACTED ARTICLE: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study
  39. Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study
  40. Quantitative ultrasound and fracture risk prediction in non-osteoporotic men and women as defined by WHO criteria
  41. Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
  42. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
  43. Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw: reply to Subramanian and Quek
  44. The Presence and Severity of Vertebral Fractures is Associated with the Presence of Esophageal Hiatal Hernia in Postmenopausal Women
  45. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
  46. Influence of fall related factors and bone strength on fracture risk in the frail elderly
  47. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women
  48. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
  49. Stroke in relation to use of raloxifene and other drugs against osteoporosis
  50. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women
  51. The relationship between low bone mass and metabolic syndrome in Korean women
  52. Effect of high-dose cholecalciferol (vitamin D 3 ) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial
  53. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
  54. Treatment of osteoporosis after alendronate or risedronate
  55. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
  56. Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women
  57. Bone mass following physical activity in young years: a mean 39-year prospective controlled study in men
  58. Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
  59. Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV)
  60. Age-related differences in the activity of arterial mineral deposition and regional bone metabolism: a 18 F-sodium fluoride positron emission tomography study
  61. Copper deficit as a potential pathogenic factor of reduced bone mineral density and severe tooth wear
  62. Has Choosing Wisely® affected rates of dual-energy X-ray absorptiometry use?
  63. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
  64. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures
  65. The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals
  66. Association between osteocalcin and glucose metabolism: a meta-analysis
  67. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study
  68. Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists
  69. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
  70. Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease
  71. Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies
  72. Both resistance and agility training reduce back pain and improve health-related quality of life in older women with low bone mass
  73. Homocysteine and fracture risk in postmenopausal women: the OFELY study
  74. Excess mortality following hip fracture: a systematic epidemiological review
  75. A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density
  76. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
  77. Weight loss and distal forearm fractures in postmenopausal women
  78. Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands
  79. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  80. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  81. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial
Search Result: